Linical Co., Ltd. (TYO:2183)
220.00
+1.00 (0.46%)
Jun 3, 2026, 3:30 PM JST
Linical Revenue
In the fiscal year ending March 31, 2026, Linical had annual revenue of 8.67B JPY, down -16.98%. Linical had revenue of 1.83B in the quarter ending March 31, 2026, a decrease of -26.37%.
Revenue
8.67B
Revenue Growth
-16.98%
P/S Ratio
0.57
Revenue / Employee
14.49M
Employees
598
Market Cap
4.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.67B | -1.77B | -16.98% |
| Mar 31, 2025 | 10.44B | -1.87B | -15.19% |
| Mar 31, 2024 | 12.31B | -209.00M | -1.67% |
| Mar 31, 2023 | 12.52B | 961.00M | 8.32% |
| Mar 31, 2022 | 11.56B | 1.28B | 12.41% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Transgenic Group | 13.17B |
| Kohjin Bio | 4.94B |
| Soiken Holdings | 4.40B |
| StemCell Institute | 2.81B |
| PRISM BioLab Co.,LTD | 711.65M |
| Chiome Bioscience | 593.29M |
| D. Western Therapeutics Institute | 305.24M |
| Kubota Pharmaceutical Holdings | 17.76M |